A naturally arising broad and potent CD4-binding site antibody with low somatic mutation

一种天然产生的广谱高效CD4结合位点抗体,具有低体细胞突变率

阅读:3
作者:Christopher O Barnes ,Till Schoofs ,Priyanthi N P Gnanapragasam ,Jovana Golijanin ,Kathryn E Huey-Tubman ,Henning Gruell ,Philipp Schommers ,Nina Suh-Toma ,Yu Erica Lee ,Julio C Cetrulo Lorenzi ,Alicja Piechocka-Trocha ,Johannes F Scheid ,Anthony P West Jr ,Bruce D Walker ,Michael S Seaman ,Florian Klein ,Michel C Nussenzweig ,Pamela J Bjorkman

Abstract

The induction of broadly neutralizing antibodies (bNAbs) is a potential strategy for a vaccine against HIV-1. However, most bNAbs exhibit features such as unusually high somatic hypermutation, including insertions and deletions, which make their induction challenging. VRC01-class bNAbs not only exhibit extraordinary breadth and potency but also rank among the most highly somatically mutated bNAbs. Here, we describe a VRC01-class antibody isolated from a viremic controller, BG24, that is much less mutated than most relatives of its class while achieving comparable breadth and potency. A 3.8-Å x-ray crystal structure of a BG24-BG505 Env trimer complex revealed conserved contacts at the gp120 interface characteristic of the VRC01-class Abs, despite lacking common CDR3 sequence motifs. The existence of moderately mutated CD4-binding site (CD4bs) bNAbs such as BG24 provides a simpler blueprint for CD4bs antibody induction by a vaccine, raising the prospect that such an induction might be feasible with a germline-targeting approach.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。